FindTrial
Sign In

Investigate the Ocular Hypertensive & Anti-inflammatory Response to 0.5% Lotemax & 1% Fluorometholone in Children

Randomized Trial to Investigate the Ocular Hypertensive & Anti-inflammatory Response to 0.5% Lotemax & 1% Fluorometholone in Chinese Children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000637
Enrollment
Unknown
Registered
2009-12-04
Start date
2005-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Two groups:0.5% Lotemax versus 0.1% fluorometholone, 1 month

Sponsors

Nil
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children age 2 to 12 Children receive bilateral strabismus operation

Exclusion criteria

Exclusion criteria: Exclusion criteria history of ocular hypertension or glaucoma eye diseases other than strabismus and refractive error family history of glaucoma application of steriod in the past 1 year.

Design outcomes

Primary

MeasureTime frame
Intraocular pressure;—

Secondary

MeasureTime frame
Inflammation;—

Countries

China

Contacts

Public ContactFAN Shu Ping Dorothy
dorothyfan@cuhk.edu.hk+852 27623168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026